19 related articles for article (PubMed ID: 38489372)
1. Chemokine-Like Factor 1 (CKLF-1) is Overexpressed in Keloid Patients: A Potential Indicating Factor for Keloid-Predisposed Individuals.
Zhang M; Xu Y; Liu Y; Cheng Y; Zhao P; Liu H; Wang Y; Ma X
Medicine (Baltimore); 2016 Mar; 95(11):e3082. PubMed ID: 26986142
[TBL] [Abstract][Full Text] [Related]
2. GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape.
Caforio M; Sorino C; Caruana I; Weber G; Camera A; Cifaldi L; De Angelis B; Del Bufalo F; Vitale A; Goffredo BM; De Vito R; Fruci D; Quintarelli C; Fanciulli M; Locatelli F; Folgiero V
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737337
[TBL] [Abstract][Full Text] [Related]
3. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
[TBL] [Abstract][Full Text] [Related]
4. GAS7 Deficiency Promotes Metastasis in MYCN-Driven Neuroblastoma.
Dong Z; Yeo KS; Lopez G; Zhang C; Dankert Eggum EN; Rokita JL; Ung CY; Levee TM; Her ZP; Howe CJ; Hou X; van Ree JH; Li S; He S; Tao T; Fritchie K; Torres-Mora J; Lehman JS; Meves A; Razidlo GL; Rathi KS; Weroha SJ; Look AT; van Deursen JM; Li H; Westendorf JJ; Maris JM; Zhu S
Cancer Res; 2021 Jun; 81(11):2995-3007. PubMed ID: 33602789
[TBL] [Abstract][Full Text] [Related]
5. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.
Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD
Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121
[TBL] [Abstract][Full Text] [Related]
6. MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.
Xue C; Yu DM; Gherardi S; Koach J; Milazzo G; Gamble L; Liu B; Valli E; Russell AJ; London WB; Liu T; Cheung BB; Marshall GM; Perini G; Haber M; Norris MD
Oncotarget; 2016 Aug; 7(34):54937-54951. PubMed ID: 27448979
[TBL] [Abstract][Full Text] [Related]
7. CKLF instigates a "cold" microenvironment to promote MYCN-mediated tumor aggressiveness.
Qin X; Lam A; Zhang X; Sengupta S; Iorgulescu JB; Ni H; Das S; Rager M; Zhou Z; Zuo T; Meara GK; Floru AE; Kemet C; Veerapaneni D; Kashy D; Lin L; Lloyd K; Kwok L; Smith KS; Nagaraju RT; Meijers R; Ceol C; Liu CT; Alexandrescu S; Wu CJ; Keskin DB; George RE; Feng H
Sci Adv; 2024 Mar; 10(11):eadh9547. PubMed ID: 38489372
[TBL] [Abstract][Full Text] [Related]
8. Cancer Research Advance in CKLF-like MARVEL Transmembrane Domain Containing Member Family (Review).
Lu J; Wu QQ; Zhou YB; Zhang KH; Pang BX; Li L; Sun N; Wang HS; Zhang S; Li WJ; Zheng W; Liu W
Asian Pac J Cancer Prev; 2016; 17(6):2741-4. PubMed ID: 27356683
[TBL] [Abstract][Full Text] [Related]
9. A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle.
Li HL; Dong LL; Jin MJ; Li QY; Wang X; Jia MQ; Song J; Zhang SY; Yuan S
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770809
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
